Can Modeling and Simulation Reduce Medtech Development Costs and Time?

 

A new project is exploring the use of simulation during development of treatments for osteoporosis, tuberculosis, multiple sclerosis, coronary stenosis, cerebral aneurysms, mammary carcinoma, and COVID-19 infection.

Read the article here: www.mddionline.com/rd/can-modeling-and-simulation-reduce-medtech-development-costs-and-time




This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy. By clicking Accept, you consent to our use of cookies.